Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

August 7, 2017

BMS and Clovis to Study Opdivo, Rubraca Combo Treatment in Prostate, Other Cancers

News

Bristol-Myers Squibb and Clovis Oncology will collaborate to assess the combination of Opdivo (nivolumab) and Rubraca (rucaparib) in Phase 2 and 3 clinical studies in patients with different cancer types, including ... Read more

June 20, 2017

Targeted Photodynamic Therapy May Help in Treatment of Prostate Cancer, Study Suggests

News

Targeted photodynamic therapy may be a potential approach to treat prostate cancer, according to the results of a new preclinical study. The study, titled “Characterization of an In-111-labeled anti-PSMA antibody-photosensitizer ... Read more

May 22, 2017May 22, 2017

Topsalysin Seen to Help Some Localized Prostate Cancer Patients in Small Study

News

Some patients with localized prostate cancer were seen to benefit from treatment with topsalysin (PRX302) in a small Phase 2a proof-of-concept trial (NCT02499848), according to Sophiris Bio. Findings from the trial ... Read more

May 5, 2017May 5, 2017

Physicians Can Be Trained to Interpret Axumin PET Images of Recurrent Prostate Cancer, Study Finds

News

A study supported by Blue Earth Diagnostics showed that physicians can be trained to successfully interpret Axumin PET scan images of patients with suspected recurrence of prostate cancer. Axumin is ... Read more

April 19, 2017April 19, 2017

Roche Launches New SP116 Antibody to Aid in Prostate Cancer Diagnosis

News

Roche says clinicians can now access its anti-p504 (SP116) antibody to help diagnose men with prostate cancer, representing a new way to detect the disease early using a simple laboratory assay. SP116, a ... Read more

April 12, 2017April 12, 2017

SelectMDx is Cost-Effective Test for Prostate Cancer Biopsy Selection, Dutch Researchers Find

News

The SelectMDx test for prostate cancer reduces overdiagnosis and overtreatment in men at risk of prostate cancer compared to PSA testing alone, MDxHealth announced. By cutting the number of unnecessary biopsies, ... Read more

April 7, 2017April 7, 2017

Nearly 40% of English, Welsh Men with Metastatic Prostate Cancer May Not Be Getting Adequate Treatment

News

Nearly 40 percent of men in England and Wales with locally advanced metastatic prostate cancer, or those at high risk of having this condition, may not be getting proper therapy, according ... Read more

March 16, 2017March 16, 2017

Mutations in SPOP Protein Trigger Onset of Prostate Cancer Subtype, Study Finds

News

Mutations in a protein called SPOP trigger the development and growth of a subtype of prostate cancer, according to a study. The findings may lead to treatments targeting the subtype, ... Read more

March 10, 2017

New Technique Identifies 10 Times More DNA Variations Associated with Prostate Cancer

News

A new approach to detecting DNA variations that may be associated with prostate cancer has found 10 times as many variations as the most common approach, according to a study. The ... Read more

March 3, 2017

CyberKnife Therapy Prevents Prostate Cancer in Men at Low to Intermediate Risk, Study Says

News

Men at low risk of prostate cancer who got radiation therapy with Accuray‘s CyberKnife System were still disease-free after seven years, as were 88.5 percent of men at intermediate risk, concluded a clinical ... Read more